Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Series/ Type

Series/type

Search tool

Displaying 41 - 52 of 52

Publications

Preventing fatal overdoses: a systematic review of the effectiveness of take-home naloxone

01.01.2015

Drug overdose is one of the major causes of death among young people in Europe. This paper considers how naloxone — an effective antidote that can reverse opioid intoxication — combined with training in first aid for coping with an overdose for people who are not health professionals can help save...

Publications

Pregnancy and opioid use: strategies for treatment

01.11.2014

Illicit opioid consumption during pregnancy brings with it the risk of an increase in obstetric complications for the mother and a range of potential dangers for the child, both before and after birth. The primary goal when treating opioid dependence in pregnant women is to stabilise the patient...

Publications

Risk Assessment Report of a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)

01.11.2014

This report presents the data and findings of the risk assessment on the new psychoactive substance, MT-45, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug in the European Union led to an assessment of the health and social...

Publications

EMCDDA–Europol Joint Report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’)

01.09.2014

In April 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine, commonly known as MT-45. The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report...

Publications

Report on the risk assessment of 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide (AH-7921) in the framework of the Council Decision on new psychoactive substances

01.05.2014

This report presents the data and findings of the risk assessment on the new psychoactive substance, 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide (AH-7921), that was conducted by the Scientific Committee of the EMCDDA. Concerns over this synthetic opioid in the European Union led...

Publications

The levels of use of opioids, amphetamines and cocaine and associated levels of harm: summary of scientific evidence

01.03.2014

This report presents the findings of a literature review to identify the most frequently occurring patterns of use and their relation to harm in users of opioids, powder and crack cocaine, and meth/amphetamine. The behavioural factors that were studied included: frequency of use, duration of use,...

Publications

EMCDDA–Europol Joint Report on new psychoactive substance AH-7921 (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide)

01.01.2014

The EMCDDA–Europol Joint Report on new psychoactive substance AH-7921 (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide), submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the available evidence, the EMCDDA and Europol concluded...

Publications

Heroin drug profile

08.05.2013

Drug profiles are scientifically sound descriptions of drugs in the form of ‘drug profiles’. Presented in a standardised way, each profile briefly gives the chemistry, pharmacology, synthesis and precursors of each substance, as well as analysis, physical form (e.g. powder, tablet) and mode of use...

Publications

Preventing opioid overdoses in Europe

01.10.2012

This report focuses on individual, situational and organisational risk factors for overdoses and how they can be modified to reduce fatal outcomes. Key risk and protective factors were categorised and their efficacy and the factors that facilitate or impede prevention were critically discussed by...

Publications

New heroin-assisted treatment

01.04.2012

The prescription of substitution drugs, such as methadone and buprenorphine, has become a mainstream, first-line treatment for opioid dependence, with around 700 000 of Europe’s 1.3 million problem opioid users receiving substitution treatment today. But a small minority of entrenched opioid users...

Publications

Monitoring the supply of heroin to Europe

01.09.2008

In recent years, anxiety in Europe has increased about the impact of record opium harvests in Afghanistan, and a decrease in heroin retail prices. This datasheet provides a condensed review of the key issues about how heroin manufactured from Afghan opium reaches European consumers via the Balkan...

Publications

Overdose — a major cause of avoidable death among young people

12.01.2005

Drug-related death is a complex phenomenon that includes both deaths from overdose and deaths indirectly related to drugs, for example from diseases spread by the sharing of injecting equipment, such as AIDS and hepatitis, and from accidents, violence and suicide under the influence of drugs.
Loading